Gilead and Novo Nordisk Present New Data from Proof-of-Concept Trial in NASH
FOSTER CITY, Calif. & BAGSVÆRD, Denmark–(BUSINESS WIRE)–Nov. 15, 202...
CDC: Prevalence of any past, present hep B infection 4.3 percent
(HealthDay)—The prevalence of any past or presen...